Bellevue Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-212
| Closed | -$59K | – | 173 |
|
|
2022
Q4 | $59K | Sell |
212
-89
| -30% | -$24.8K | ﹤0.01% | 163 |
|
|
2022
Q3 | $63K | Buy |
301
+108
| +56% | +$22.6K | ﹤0.01% | 165 |
|
|
2022
Q2 | $45K | Buy |
+193
| New | +$45K | ﹤0.01% | 167 |
|
|
2018
Q1 | – | Sell |
-17,200
| Closed | -$2.55M | – | 135 |
|
|
2017
Q4 | $2.55M | Sell |
17,200
-4,400
| -20% | -$651K | 0.27% | 72 |
|
|
2017
Q3 | $2.53M | Buy |
21,600
+13,800
| +177% | +$1.62M | 0.26% | 74 |
|
|
2017
Q2 | $1.01M | Hold |
7,800
| – | – | 0.12% | 103 |
|
|
2017
Q1 | $1.06M | Hold |
7,800
| – | – | 0.14% | 101 |
|
|
2016
Q4 | $1.12M | Buy |
7,800
+1,500
| +24% | +$215K | 0.23% | 80 |
|
|
2016
Q3 | $744K | Hold |
6,300
| – | – | 0.13% | 107 |
|
|
2016
Q2 | $667K | Sell |
6,300
-13,000
| -67% | -$1.38M | 0.13% | 107 |
|
|
2016
Q1 | $2.33M | Buy |
+19,300
| New | +$2.33M | 0.42% | 72 |
|